Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -9.58M
March 31, 2026 -15.70M
December 31, 2025 -11.10M
September 30, 2025 -7.849M
June 30, 2025 -15.23M
March 31, 2025 -12.07M
December 31, 2024 -10.92M
September 30, 2024 -16.32M
June 30, 2024 -11.24M
March 31, 2024 -11.21M
December 31, 2023 -12.03M
September 30, 2023 -18.61M
June 30, 2023 -16.28M
Date Value
March 31, 2023 -19.45M
December 31, 2022 -19.23M
September 30, 2022 -16.06M
June 30, 2022 -15.53M
March 31, 2022 -20.23M
December 31, 2021 -13.70M
September 30, 2021 -11.40M
June 30, 2021 -12.46M
March 31, 2021 -15.71M
December 31, 2020
September 30, 2020
June 30, 2020 -7.258M
March 31, 2020 -6.137M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. -0.547M
Medpace Holdings, Inc. 138.10M
Avantor, Inc. 140.60M
Personalis, Inc. -29.55M
Adaptive Biotechnologies Corp. -7.584M